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Stimulation of CD95/Fas/APO-1 results in the induction of both apoptotic and non-apoptotic signaling pathways. The processes
regulating these two opposing pathways have not been thoroughly elucidated to date. In this study, using quantitative
immunoblots, imaging, and mathematical modeling, we addressed the dynamics of the DED proteins of the death-inducing
signaling complex (DISC), procaspase-8, and cellular FLICE inhibitory proteins (c-FLIPs) to the onset of CD95-mediated ERK1/2
and p38 mitogen-activated protein kinase (MAPK) activation. We found that CD95 DISC-induced caspase-8 activity is important
for the initiation of ERK1/2 and p38 MAPK activation. The long c-FLIP isoform, c-FLIPL, and the short c-FLIP isoform, c-FLIPR,
inhibitedMAPK induction byblockingcaspase-8processingattheDISC.Furthermore, webuiltamathematicalmodeldescribing
CD95 DISC-mediated MAPK activation and apoptosis. The model quantitatively deﬁned the dynamics of DED proteins,
procaspase-8, and c-FLIP, which lead to caspase-8 activation and induction of apoptotic and non-apoptotic signaling pathways.
In conclusion, the combination of biochemical analysis with mathematical modeling provides evidence for an important role of
caspase-8 in CD95-mediated activation of MAPKs, while c-FLIP exerts a regulatory function in this process.
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CD95 (APO-1/Fas)
1 is a member of the death receptor (DR)
family. Stimulation of CD95 with its natural ligand CD95L or
with agonistic anti-CD95 antibodies, such as anti-APO-1,
induces apoptosis in sensitive cells.
1 Stimulation of CD95 has
alsobeenreportedtoinducenon-apoptoticpathways,suchas
NF-kB, Akt, ERK, and others.
2 The death-inducing signaling
complex (DISC) is formed within seconds after CD95
stimulation.
3 The DISC comprises oligomerized CD95, the
adaptor protein FADD, two isoforms of procaspase-8 (pro-
caspase-8aand procaspase-8b), procaspase-10,and cellular
FLICE inhibitory proteins (c-FLIPs).
1,4–6
After binding to the DISC, procaspase-8a/b (p55/p53)
homodimers undergo a conformational change and auto-
catalytic processing that results in the generation of active
caspase-8.
1,7 Procaspase-8a/b processing at the DISC
involves cleavage at several Asp (D) residues between the
prodomain and the small and large catalytic subunits
(Supplementary Figure S1A). This results in the formation of
the N-terminal cleavage products p43/p41, the prodomains
p26/p24, as well as the C-terminal cleavage products p30,
p18, and p10.
8,9 It was proposed that the intrinsic catalytic
activity of procaspase-8 and active caspase-8 bear highly
restricted substrate repertoires. The catalytic activity of
procaspase-8 was shown to be limited to procaspase-8
itself and c-FLIP.
7,8,10 In contrast, mature caspase-8 does
not cleave procaspase-8 molecules, but efﬁciently processes
effector procaspases, thus triggering the apoptotic signal.
11
These different substrate speciﬁcities might in part contri-
bute to the regulation of apoptosis and play a role in trigger-
ing either apoptotic or non-apoptotic CD95 signaling
cascades.
8
c-FLIP is a well-described inhibitor of DR-mediated
apoptosis. Three c-FLIP isoforms and two cleavage products
have been characterized so far.
12–15 The three c-FLIP
isoforms include: long (L), short (S), and Raji (R), that is,
c-FLIPL, c-FLIPS, and c-FLIPR, respectively (Supplementary
Figure S1B). All three isoforms possess two DED domains
and are therewith capable of binding to the DISC, where
they competitively inhibit caspase-8 recruitment. Heterodimer
formation of procaspase-8 and c-FLIP at the DISC results
in procaspase-8 activation and in procaspase-8-mediated
cleavage of c-FLIP. In addition to their antiapoptotic role in
DR-induced apoptosis, c-FLIP proteins and their cleavage
products, p43-FLIP and p22-FLIP, were demonstrated to play
a prominent role in the engagement of NF-kB signaling
(Supplementary Figure S1B).
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www.nature.com/cddisRecently, it has been reported that CD95L is not only a
potent inducer of apoptosis, but can also activate multiple
non-apoptotic pathways, in particular induction of mitogen-
activated protein kinases (MAPKs).
2,17–21 MAPKs are im-
plicated in growth, proliferation, differentiation, migration, and
apoptosis. It has been reported that activation of the
ERK MAPK pathway upon CD95 crosslinking has a func-
tional implication in nerve recovery
22 and prevention of
CD95-induced apoptosis.
23 In addition, CD95 signaling was
shown to activate p38 MAPK.
24 Although caspase activity has
been reported to be involved in CD95-mediated MAPK
activation in previous studies,
17,21,24 the distinct mechanisms
of ERK and p38 MAPK activation following CD95 triggering
remain elusive.
Studies of CD95 signaling and apoptosis using systems
biology have recently provided signiﬁcant insights into
quantitative regulation of these processes. A number of
models describe the regulation of caspase activation,
25,26 the
intrinsic pathway,
27 and the extrinsic pathway regulation.
28–30
In addition, a model of the interplay between CD95-mediated
apoptosis and NF-kB induction has been reported recently.
16
Nevertheless, a model describing the crosstalk between
CD95-mediated apoptosis and MAPK activation has still
been missing.
The aim of this study is to provide new insights into the
mechanisms at the DISC, leading to the activation of MAPKs
upon stimulation of CD95, in particular to delineate the role of
procaspase-8 and c-FLIP isoforms in this process. Activation
of the MAPK family members, ERK1/2 and p38, upon CD95
stimulation was quantitatively analyzed using HeLa cell lines
overexpressing CD95 (HeLa-CD95 cells)
16,30 with different
expression levels of c-FLIP isoforms and procaspase-8.
Experimental data supported by mathematical modeling
demonstrated that the degree of procaspase-8 activation at
the DISC, which is regulated by c-FLIP proteins, is directly
linked to the degree of CD95-mediated induction of MAPKs,
highlighting the crucial role of caspase-8 activity in this
signaling pathway.
Results
CD95 stimulation leads to a dose-dependent MAPK
activation in HeLa-CD95 cells. To understand the
mechanisms of CD95-mediated MAPK activation in
mechanistic and quantitative terms, we utilized HeLa-CD95
cell lines that have been established in our lab.
16,30 These
are the only available cell lines, in which the precise
concentrations of the major apoptotic modulators have
been deﬁned. The exact number of the major DISC
components, that is, procaspase-8, c-FLIP, FADD, and
CD95, in these cell lines as well as quantitative responses
with respect to CD95-mediated apoptosis and NF-kB
induction have been determined in our previous work.
16,30
Accordingly, these cell lines constitute an ideal tool for further
investigation of the initial events of CD95-mediated MAPK
activation. Furthermore, we have generated HeLa-CD95
cells with different levels of c-FLIP and procaspase-8 by
downregulation and overexpression of these proteins.
16,30
Our panel of HeLa-CD95 cells comprised: HeLa-CD95 cells
with c-FLIPR overexpression (HeLa-CD95-FR), HeLa-CD95
cells with c-FLIPL overexpression (HeLa-CD95-FL), HeLa-
CD95 cells with caspase-8 downregulation (HeLa-CD95-C8
dr), and HeLa-CD95 cells with c-FLIP downregulation (HeLa-
CD95-F dr).
Upon stimulation with agonistic anti-APO-1 antibodies,
HeLa-CD95 cells underwent apoptosis as observed by
morphological changes characteristic for apoptotic cell death
in live cell imaging (Figure 1). In accordance with previous
reports,overexpressionofc-FLIPisoformsanddownregulation
ofcaspase-8decreasedthe ratesofapoptosis(Figure1b).
16,30
To characterize CD95-mediated activation of MAPKs,
HeLa-CD95 cells were treated with either 250 or 1500ng/ml
anti-APO-1. Immunoblot (IB) analysis of phosphorylated
ERK1/2 and p38 showed that these MAPKs were highly
activateduponstimulationofCD95withanti-APO-1(Figure2).
The onset of activation was found to be stimulus-dependent
for both ERK1/2 and p38. ERK1/2 activation ﬁrst peaked at
90min for a stimulus of 250ng/ml anti-APO-1, whereas
stimulation with 1500ng/ml anti-APO-1 led to a ﬁrst peak
of ERK1/2 activation already at 60min (Figure 2a). Remark-
ably, ERK1/2 activation subsequently decreased before it
reached a second peak at about 180min for a stimulus of
250ng/ml anti-APO-1 and at 120min for stimulation with
1500ng/ml anti-APO-1 (Figure 2a). Similar to ERK1/2, p38
also showed an earlier detectable onset of activation with the
higher stimulus (Figure 2b). In contrast to the biphasic
activation of ERK1/2, activation of p38 steadily increased
with time (Figure 2b).
The phosphorylation of MAPKs was accompanied by
CD95-triggered cleavage of c-FLIPL into p43-FLIP and
procaspase-8a/b processing into p43/p41, p30, and p18
(Figure 2). The appearance of cleavage products was found
to be stimulus-dependent in accordance with previous
reports:
9,30 c-FLIPL and procaspase-8a/b cleavage products
appeared earlier upon stimulation of CD95 with 1500ng/ml
anti-APO-1 than with 250ng/ml anti-APO-1. These data show
that CD95 stimulation with anti-APO-1 induces the activation
of ERK1/2 and p38 MAPKs in a dose-dependent manner,
which,in turn,directly correlateswithkinetics ofprocaspase-8
cleavage.
c-FLIP proteins inhibit CD95-mediated MAPK
activation. c-FLIP proteins have been reported to be
important regulators of CD95-mediated apoptosis and
NF-kB induction.
16 To determine whether c-FLIP proteins
play a regulatory role in CD95-mediated activation of
MAPKs, we used HeLa-CD95 cell lines with stable
overexpression or downregulation of c-FLIP isoforms.
Overexpression of c-FLIPR or c-FLIPL in HeLa-CD95 cells
reduced the activation of MAPKs upon CD95-stimulation
(Figure 3 and Supplementary Figures S2 and S3). A
comparison between MAPK activation in HeLa-CD95 and
HeLa-CD95-FR cells demonstrated that overexpression of
c-FLIPR strikingly reduced activation of both ERK1/2 and p38
(Figure 3 and Supplementary Figure S3). The amounts of
phosphorylated ERK1/2 and p38 were quantiﬁed and normal-
ized to tubulin, which served as a loading control. Alignments
of time series from repeated experiments were performed to
obtain comparability (Figures 3b and d). Overexpression of
DISC-mediated MAPK activation
AMM Kober et al
2
Cell Death and Diseasec-FLIPR inhibited processing of procaspase-8 and c-FLIPL,
which is in accordance with previous publications on the
inhibitory role of c-FLIPR.
13 Consistent with this observa-
tion, the procaspase-8a/b cleavage products p43/p41
and p18 were clearly detectable upon stimulation in HeLa-
CD95 cell lysates, but not in HeLa-CD95-FR cell lysates
(Figures 3a and c).
Comparable results were obtained for HeLa-CD95-FL cells.
Overexpression of c-FLIPL substantially reduced activation of
ERK1/2 and p38 upon stimulation with anti-APO-1 (Supple-
mentary Figure S2). These data demonstrate that over-
expression of c-FLIPR or c-FLIPL reduced CD95-mediated
activation of MAPKs and resulted in incomplete processing of
procaspase-8a/b.
To further analyze the role of c-FLIPs in CD95-mediated
activationofMAPKs,ansiRNAconstructtargetingc-FLIPwas
stably transfected into HeLa-CD95 cells to generate the
HeLa-CD95-F dr cell line with downregulation of c-FLIP. The
corresponding HeLa-CD95-F ctrl control cell line was gener-
ated by transfection of an empty vector control. Quantiﬁcation
of c-FLIP downregulation in the unstimulated case for all
experiments averaged out at a downregulation by 68% in
comparisontothecontrolcellline.HeLa-CD95,HeLa-CD95-F
dr, and HeLa-CD95-F ctrl were stimulated with 1000ng/ml
anti-APO-1 for 15–120min and total cellular lysates were
analyzed by IB (Figure 4 and Supplementary Figure S4).
Interestingly, c-FLIP downregulation was found to reduce
CD95-mediated activation of ERK1/2 and p38 (Figure 4),
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Figure 1 Apoptotic cell death of HeLa-CD95 cell lines upon stimulation with 1000ng/ml anti-APO-1. Different HeLa-CD95 cell lines were stimulated with 1000ng/ml anti-
APO-1 and subjected to time-lapse microscopy. (a) Representative images for HeLa-CD95 cells are shown. Apoptosis was detected based on morphological characteristics
associated with apoptotic cell death, including condensation of the cytoplasm, membrane blebbing, and formation of apoptotic bodies. White arrows indicate a cell that
shows typical characteristics of apoptotic cell death, that is, condensation of the cytosol (45 and 60min), membrane blebbing (180min), and formation of apoptotic bodies
(270min). (b) For the indicated points in time, the number of cells showing onset of apoptosis characterized by cytoplasm condensation and the total number of cells were
counted to determine the percentage of apoptotic cell death. Displayed results are averaged values for ﬁve images per cell line and time. HeLa-CD95, HeLa cell line
overexpressing CD95; HeLa-CD95-FR, HeLa-CD95 cells with c-FLIPR overexpression; HeLa-CD95-FL, HeLa-CD95 cells with c-FLIPL overexpression; HeLa-CD95-C8 dr,
HeLa-CD95 cells with caspase-8 downregulation; HeLa-CD95-F dr, HeLa-CD95 cells with c-FLIP downregulation; HeLa-CD95-F ctrl, corresponding control cell line to HeLa-
CD95-F dr
DISC-mediated MAPK activation
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Cell Death and Diseasealbeit to a lesser extent than by overexpression of c-FLIPL
or c-FLIPR. Remarkably, less caspase-8 cleavage
product p18 was detectable upon c-FLIP downregulation
(Figures 4a and c).
According to these data, both overexpression and down-
regulation of c-FLIP reduce CD95-mediated activation of
MAPKs and procaspase-8a/b processing. These ﬁndings
indicate that c-FLIP exhibits a regulatory function with
properties depending on its cellular concentration.
Caspase-8 plays the major role in CD95-mediated
activation of MAPKs. The unifying characteristic inhibiting
MAPK activation in so far studied conditions is a reduced
processing of procaspase-8 reﬂected by the lower amount
of procaspase-8a/b cleavage products. Therefore, the role
of procaspase-8 and active caspase-8 was further investi-
gated. Treatment of HeLa-CD95 cells (Supplementary
Figure S5) and HeLa-CD95 cells overexpressing c-FLIPL or
c-FLIPR (Supplementary Figure S6) with the pan-caspase
inhibitor zVAD-fmk inhibited phosphorylation of ERK1/2 and
p38. These data provided the ﬁrst hint at the involvement
of caspase activity in CD95-mediated MAPK activation in
our system.
To analyze caspase-8 involvement in CD95-mediated
activation of MAPKs more directly, the HeLa-CD95-C8 dr cell
line with stable downregulation of caspase-8 by RNA
interference
16 was used. HeLa-CD95 and HeLa-CD95-C8 dr
cells were stimulated with 1000ng/ml anti-APO-1 for time
periods ranging between 15 and 180min. Downregulation of
caspase-8 substantially reduced activation of ERK1/2 and
p38 upon CD95 stimulation (Figure 5 and Supplementary
FigureS7).Quantiﬁcationofprocaspase-8a/bdownregulation
in the unstimulated case for all experiments averaged out at a
downregulation by 60%. In contrast to HeLa-CD95 cell
lysates, almost no active procaspase-8a/b cleavage products
p43/p41, p30, and p18 were detectable in HeLa-CD95-C8 dr
cell lysates. These data suggest that procaspase-8 and its
processing are required for CD95-mediated activation of
MAPKs.
Modeling revealed that the ratio of procaspase-8 to
c-FLIP at the DISC plays the crucial role in CD95-
mediated MAPK activation. Our experimental measure-
ments suggested that MAPK activation occurs downstream
of DISC formation and caspase-8 activation. To further
conﬁrm this hypothesis, we included caspase-8-mediated
Figure 2 Anti-APO-1 concentration-dependent onset of ERK and p38 MAPK activation. HeLa-CD95 cells were stimulated with 250 or 1500ng/ml anti-APO-1 for the
indicated time periods. Total cellular lysates were analyzed by SDS-PAGE and IB using the indicated primary antibodies. Representative IB results for ERK (a) and p38 (b)
activation are shown. Asterisks indicate nonspeciﬁc bands
DISC-mediated MAPK activation
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Cell Death and DiseaseFigure 3 Reduced activation of ERK and p38 upon c-FLIPR overexpression. HeLa-CD95 and HeLa-CD95-FR cells were stimulated with 1000ng/ml anti-APO-1
fortheindicatedtimeperiods.TotalcellularlysateswereanalyzedbySDS-PAGEandIBusingtheindicatedprimaryantibodies.RepresentativeIBresultsforERK(a)andp38
(c) activation as well as the averaged quantiﬁed signals of scaled time courses with standard deviations of all performed experiments (b and d) are shown. Displayed results
are representative of two (0–120min) and additional three (ERK) or two (p38) (0–60min) independent experiments. HeLa-CD95-FR, HeLa-CD95 cells with c-FLIPR
overexpression. Asterisks indicate nonspeciﬁc bands. Independent repeats of these experiments are shown in Supplementary Figure S3
Figure 4 Reduced activation of ERK and p38 upon c-FLIP downregulation. HeLa-CD95, HeLa-CD95-F ctrl, and HeLa-CD95-F dr cells were stimulated with 1000ng/ml
anti-APO-1fortheindicatedtimeperiods.TotalcellularlysateswereanalyzedbySDS-PAGE andIB usingtheindicatedprimaryantibodies.RepresentativeIBresultsforERK
(a) and p38 (c) activation as well as the averaged quantiﬁed signals of scaled time courses with standard deviations of all performed experiments (b and d) are shown.
Displayed results are representative for four independent experiments. HeLa-CD95-F dr, HeLa-CD95 cells with c-FLIP downregulation; HeLa-CD95-F ctrl, control cell line
without c-FLIP downregulation. Independent repeats of these experiments are shown in Supplementary Figure S4
DISC-mediated MAPK activation
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Cell Death and DiseaseMAPK activation in our previously published mathematical
model
30 and compared the model trajectories to
experimental time-course data. For simplicity, the analysis
was restricted to p38 activation. In the model, p38
phosphorylation was assumed to be directly activated by
enzymatically active caspase-8 (Supplementary Figure S8).
In addition, we considered a p38 dephosphorylation step in
the model and assumed it to be not regulated by caspase-8.
The ordinary differential equations of the model can be found
in the Supplementary Material.
Our previously published model
30 was based on time-
course measurements in HeLa-CD95 cells stimulated with
CD95L, while agonistic anti-APO-1 antibodies were used as
the stimulus in this work. Moreover, the present data set
includesanovelexperimentalconditionthatwaslackinginthe
calibration of the previous model (i.e., caspase-8 down-
regulation). We, therefore, derived an improved model by
simultaneously ﬁtting all kinetic parameters to the anti-APO-1
and CD95L data sets. Speciﬁcally, we assumed that CD95L
and anti-APO-1 stimulation conditions solely differ in the
biologically active ligand concentration and the ligand binding
rate, whereas the kinetic parameters of intracellular reactions
are the same for both conditions (see Supplementary Material
for ﬁtted parameters). The trajectories of the best-ﬁt model lie
within the experimental error (Figure 6a and Supplementary
Figure S9). This further supports our hypothesis that p38
activation occurs downstream of caspase-8 activity.
The model could reproduce our experimental observation
that c-FLIP downregulation and overexpression both block
procaspase-8 processing and p38 activation in response to
anti-APO-1 stimulation (Figure 6). However, in our previous
work, we observed that c-FLIP downregulation does not
signiﬁcantly affect procaspase-8 processing upon CD95L
stimulation of HeLa-CD95 cells.
30 The model explains these
different observations upon c-FLIP downregulation by a
ligand-speciﬁc effect considering that the activity of anti-
APO-1 is lower than the activity of CD95L. As procaspase-8 is
processed more rapidly in c-FLIPL-procaspase-8 hetero-
dimers than in procaspase-8 homodimers,
30 c-FLIPL down-
regulation can possibly reduce procaspase-8 activation. The
absolute concentrations of c-FLIP proteins (each B500
molecules per cell) in HeLa-CD95 cells are much lower than
thoseof CD95 (150000 molecules per cell) andprocaspase-8
(250000 molecules per cell).
30 Given that c-FLIP binds to the
CD95 DISC with much higher afﬁnity than its by far more
abundant competitor procaspase-8, and that in our model,
anti-APO-1 activates slightly less than half of the CD95 pool,
while CD95L activates the whole receptor pool, the contribu-
tion of c-FLIP heterodimers to procaspase-8 processing are
more pronounced upon anti-APO-1 stimulation when com-
pared to CD95L.
Caspase-8 activity is essential to MAPK activation in
response to anti-APO-1 stimulation (see above). Formation
of p18 occurs at the DISC by processing of p43/p41 and is
modulated by c-FLIP. We, therefore, hypothesized that p18
formation and MAPK activation are controlled by the ratio of
p43/p41 and p43-FLIP at the DISC. Thus, the relative
concentrations of p43-FLIP and p43/p41 at the DISC were
analyzed in silico (Figure 6b). The simulations reveal that the
absolute concentrations of p43/p41 and p43-FLIP are poor
predictors of p18 formation: for instance, c-FLIPL overexpres-
sion or c-FLIP downregulation hardly affect maximal DISC
Figure 5 Reduced activation of ERK and p38 upon caspase-8 downregulation. HeLa-CD95 and HeLa-CD95-C8 dr cells were stimulated with 1000ng/ml anti-APO-1 for
theindicatedtimeperiods.TotalcellularlysateswereanalyzedbySDS-PAGEandIBusingtheindicatedprimaryantibodies.RepresentativeIBresultsforERK(a)andp38(c)
activation as well as the averaged quantiﬁed signals of scaled time courses with standard deviations of all performed experiments (b and d) are shown. Displayed results are
representative forthree(0–180min)andadditionaltwo(0–120min) independentexperiments.HeLa-CD95-C8dr, HeLa-CD95 cellswithcaspase-8downregulation. Asterisks
indicate nonspeciﬁc bands. Independent repeats of these experiments are shown in Supplementary Figure S7
DISC-mediated MAPK activation
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Cell Death and Diseaserecruitment of procaspase-8 despite having signiﬁcant impact
on p18 formation (Figure 6b). Likewise, p43-FLIP generation
at the DISC is essentially unchanged upon procaspase-8
downregulation or c-FLIPR overexpression (Figure 6b). How-
ever,wenotethatall conditionswithdiminished p18formation
are characterized by a strong alteration in the p43-FLIP to
p43/p41 ratio at the DISC (Figure 6b). This supports our
hypothesis that the c-FLIP/procaspase-8 ratio is the key to
CD95-induced MAPK activation.
To verify that our model indeed captures the dynamics of
protein recruitment and generation of cleavage products at
the DISC, we analyzed DISC formation in HeLa-CD95 cells
and in HeLa-CD95 cells upon downregulation of procaspase-8
(Figure 7 and Supplementary Figure S10). The model
predicted that procaspase-8 downregulation delays p43-FLIP
generation at the DISC, but does not affect its ﬁnal level
(Figure 6b). With a stimulus of 1000ng/ml anti-APO-1, p43-
FLIP at the DISC indeed reached an early saturation level at
around 20min in HeLa-CD95 cells (Figures 7a and b). In
contrast, the amount of p43-FLIP at the DISC continued to
increase in HeLa-CD95-C8 dr cells within 60min of stimula-
tion with anti-APO-1. Moreover, after 20min the level of
p43-FLIP was observed to be lower in HeLa-CD95-C8 dr
cells than in HeLa-CD95 cells. Taken together, the experi-
ments conﬁrm the decelerated p43-FLIP generation in
HeLa-CD95-C8 dr cells as predicted by the model. However,
experimentaldataandthemodelslightlydisagreedatlatetime
points: the model suggested that the ﬁnal level of
p43-FLIP should be unaffected by caspase-8 downregulation,
while the experimentally measured p43-FLIP reached a
comparably higher level in HeLa-CD95-C8 dr cells after
60min. The model also predicted that the generation of
p43/p41attheDISCshouldbesigniﬁcantlydecreased,atboth
early and late points of time (Figure 6b, top). This prediction
agrees well with experimental data (Figure 7a). We conclude
that our model captures the dynamics of protein recruitment to
the DISC, and that the ratio of p43/p41 and p43-FLIP at the
DISC is dramatically altered in cells with the downregulation of
procaspase-8. These effects were found to be even more
pronounceduponstimulationwiththelowerstimulusof250ng/ml
anti-APO-1 (Figures 7c and d). The observation of an altered
ratio of c-FLIP to procaspase-8 at the DISC further conﬁrms
the data obtained in the present work that demonstrate an
essential role for c-FLIP proteins and procaspase-8 in CD95-
mediated activation of ERK1/2 and p38 MAPKs.
Discussion
ThepivotalroleofCD95signalingintheinductionofapoptosis
is well established. Nevertheless, CD95 signaling is also
Figure 6 The best-ﬁt model captures time courses of caspase-8/MAPK activation and predicts the dynamics of DISC formation. (a) Model ﬁts to experimental
measurements of p55/p53 procaspase-8, caspase-8 cleavage products p43/p41 and p18, as well as phospho-p38 (pp38) in response to stimulation with 1000ng/ml anti-APO-1.
Each column corresponds to measurements in one of the HeLa-CD95 cell lines (indicated on top), and each row corresponds to one molecular species (indicatedon the left).
All kinetic parameters of the model (except the ligand concentration and the ligand binding rate) were ﬁtted globally to measurements in anti-APO-1 and CD95L-stimulated
HeLa-CD95 cells (see Supplementary information for kinetic parameters and ﬁts to CD95L data). (b) Predicted dynamics of p43/p41 and p43-FLIP recruitment to the DISC in
response to stimulation with 1000ng/ml anti-APO-1. Each color corresponds to one of the HeLa-CD95 cell lines as indicated in the legend
DISC-mediated MAPK activation
AMM Kober et al
7
Cell Death and Diseaseinvolved in mediating non-apoptotic pathways. Most promi-
nently, NF-kB and MAPKs are activated upon stimulation of
CD95.
16,22,31–33 As details of these processes remain
unknown, the underlying mechanisms are currently under
investigation. Caspase-8 and c-FLIP molecules have been
attributed crucial roles in both apoptotic and non-apoptotic
signaling of CD95.
In this study, a ﬁrst integrated kinetic model of CD95-
mediated apoptosis and MAPK signaling was proposed. The
model together with experimental data obtained using over-
expression of c-FLIPL, c-FLIPR or downregulation of c-FLIP,
as well as inhibition of caspases by zVAD-fmk or down-
regulation of caspase-8, allowed to make a number of
important ﬁndings. It was demonstrated that caspase-8
activity plays the central role in CD95-mediated MAPK
induction. Furthermore, it was found in silico with the following
experimental conﬁrmation that it is the ratio of c-FLIP to
procaspase-8 at the DISC which plays the central role in the
regulation of MAPK induction by deﬁning the amount of active
caspase-8 generated at the DISC. It has been reported
beforethatcaspaseactivityplaysacrucialroleintheinduction
of the MAPK pathway.
17,21 In our study, we deﬁned that this
caspase activity is attributed to the DISC-derived caspase-8
activity and quantitatively analyzed the contribution of DISC
dynamics to MAPK activation.
c-FLIPLandc-FLIPRwereshowntohavedifferentfunctions
in CD95 stimulation. c-FLIPR acts as an antiapoptotic
regulator at the DISC and blocks the activation of procas-
pase-8.
1 In contrast, the relative cellular concentration of
c-FLIPL in part determines whether c-FLIPL exerts a pro- or
antiapoptotic function. Although overexpression of c-FLIPL
inhibits activation of procaspase-8, lower concentrations of
c-FLIPL can promote cleavage of procaspase-8.
30 Consistent
with these data, overexpression of c-FLIPR or c-FLIPL in
HeLa-CD95 cells inhibited the generation of caspase-8
cleavage products in this work. Moreover, cell death occurred
to a lesser extent in HeLa-CD95-FR or HeLa-CD95-FL cells
compared to HeLa-CD95 cells.
Both c-FLIP downregulation and overexpression were
demonstrated to block procaspase-8 processing and MAPK
activation inresponse toanti-APO-1 stimulation. Procaspase-
8 is processed more rapidly in c-FLIPL-procaspase-8 hetero-
dimers than in procaspase-8 homodimers.
30 Thus, c-FLIPL
can have a catalytic effect on procaspase-8 processing, that
is, its downregulation can reduce procaspase-8 activation.
This was observed in our experiments and further conﬁrmed
using modeling.
A mechanism has been proposed in which catalytic activity
and substrate speciﬁcity of caspase-8 are determined by
conformation and cleavage status of procaspase-8.
8 Speci-
ﬁcally, it was suggested that the substrate repertoire of
procaspase-8 is restricted to itself and c-FLIP, whereas the
active p43/p41-p10 exhibits a broader substrate repertoire,
including procaspase-3 and Bid. In this work, procaspase-8
processingisrequiredforCD95-inducedactivationofMAPKs,
astheconditionsimpairingMAPKactivationareaccompanied
by reduced procaspase-8 processing. Both the ﬁrst and the
second cleavage step are in part affected, pointing out the
potential role of p43/p41 and p18 in MAPK activation. The
substrate of caspase-8 activity leading to MAPK activation
has to be elucidated in the future. In addition, procaspase-10,
thesecondinitiatorcaspaseattheDISC,mightalsocontribute
Figure 7 Altered ratio of c-FLIP/C8 at the DISC upon caspase-8 downregulation and altered kinetics with lower stimulus at the DISC. HeLa-CD95 cells and HeLa-CD95-C8 dr
cellsweretreatedwith1000or250ng/mlanti-APO-1fortheindicatedtimeperiodsandIPoftheDISCwasperformed.TotalcellularlysatesandIPsoftheDISCwereanalyzed
by SDS-PAGE and IB using the indicated primary antibodies. Representative IB results (a and c) and the quantiﬁcation for the displayed IB (b and d) are shown. Displayed
results are representative of two independent experiments. HeLa-CD95-C8 dr, HeLa-CD95 cells with caspase-8 downregulation. Asterisks indicate nonspeciﬁc bands.
Independent repeats of these experiments are shown in Supplementary Figure S10
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that it could not substitute caspase-8 in its apoptotic function.
6
However,thecontributionofprocaspase-10totheinductionof
non-apoptotic pathways remains to be addressed.
In our modeling approach, we concentrated on early
signaling events, which occurred within a few hours after
CD95 stimulation. It will be a future challenge to combine a
model of CD95-mediated signal transduction with a model of
transcriptional regulation to understand the possible feedback
from transcriptional regulation by MAPKs on upstream CD95
signaling. In addition, a combination of the CD95-mediated
MAPK model with our recent model of the crosstalk between
CD95-mediated NF-kB induction and apoptosis
16 would
provide a more generic view on the mechanism of life/death
decisions at CD95.
Our results support the new paradigm in CD95 signaling
that the CD95 DISC can act as a main switch deciding
between life and death.
20 Furthermore, we have shown in
quantitative terms that the balance between c-FLIP and
procaspase-8 regulates the onset of MAPK activation.
Interestingly, dynamics of c-FLIP and procaspase-8 at the
DISCisalsoacentralregulatorypointforNF-kBinductionand
apoptosis. These regulatory mechanisms provide an impor-
tant basis for understanding the crosstalk between non-
apoptotic and apoptotic signaling pathways. This knowledge
will provide new insights into multiple diseases, in particular
with regard to the sensitivity and resistance of cancer cells
towards apoptosis, as modulation of the ratio between
procaspase-8 and c-FLIP in cancer cells might inﬂuence their
resistance towards apoptosis.
Materials and Methods
Cell lines. HeLa-CD95 was generated by selection with 20ng/ml puromycin
according to standard protocols.
30 Stable c-FLIPL and c-FLIPR cell lines were
selected with 100mg/ml G418 and 100mg/ml zeocin, respectively.
30 HeLa-CD95
cellswere maintainedin DMEM (Life Technologies,Germany),10mM HEPES (Life
Technologies), 50mg/ml gentamycin (Life Technologies), and 10% fetal calf serum
(Life Technologies) in 5% CO2. Transfections were carried out using Lipofectamine
2000 (Invitrogen).
Antibodiesandreagents. Anti-caspase-8monoclonalantibodyC15(mouse
IgG2b) recognizes the p18 subunit of caspase-8.
5 Anti-FLIP monoclonal antibody
NF6 (mouse IgG1) recognizes the N-terminal part of c-FLIP.
12 Anti-FADD
monoclonal antibody 1C4 (mouse IgG1) recognizes the C-terminal part of FADD.
Anti-APO-1 (anti-CD95) is an agonistic monoclonal antibody (IgG3) recognizing an
epitope on the extracellular part of CD95 (APO-1/Fas). In addition, we used C20
rabbitpolyclonalCD95antibody(SantaCruzBiotechnology,Heidelberg,Germany),
anti-p38 monoclonal antibody 5F11 (mouse IgG2b; Cell Signaling Technology,
Frankfurt/Main, Germany), anti-phospho-p38 rabbit polyclonal (Promega,
Mannheim, Germany), anti-phospho-Erk monoclonal antibody (mouse IgG2a;
Santa Cruz Biotechnology), anti-Erk monoclonal antibody (mouse IgG1; BD Signal
Transduction, Heidelberg, Germany), and anti-tubulin monoclonal antibody (mouse
IgG1; Sigma-Aldrich Steinheim, Germany). Horseradish peroxidase-conjugated
goat anti-mouse IgG1, -2a and -2b were from Southern Biotechnology Associates
(Echingen, Germany). All chemicals used were of analytical grade and purchased
from Merck (Darmstadt, Germany) or Sigma-Aldrich (Steinheim, Germany).
Analysis of total cellular lysates. A total of 1 10
7 cells were either
treated with indicated amounts of anti-CD95 for indicated periods of time at 371Co r
left untreated, washed twice in 1  PBS and lysed subsequently in lysis buffer
(30mM Tris/HCl, pH 7.5, 150mM NaCl, 2mM EDTA, 1mM phenylmethylsulfonyl
ﬂuoride(Sigma),proteaseinhibitorcocktail,1%TritonX-100(Serva,Germany),and
10% glycerol). If pretreated with zVAD-fmk, cells were pre-incubated for 30min at
371C with the indicated concentrations of zVAD-fmk before stimulation. Total
cellularlysateswereanalyzedusingSDS-PAGEgels.Proteinsweretransferredtoa
Hybond nitrocellulose membrane (Amersham Pharmacia Biotech, Freiburg,
Germany), blocked with 5% non-fat dry milk in PBS/Tween (PBS with 0.05%
Tween-20) for 1h, washed with PBS/Tween, and incubated with the primary
antibody in PBS/Tween overnight at 41C. For all phospho-speciﬁc antibodies
TBS/Tween (TBS with 0.05% Tween-20) was used. Blots were developed with
a chemoluminescence method according to the manufacturer’s protocol (Perkin-
Elmer Life Sciences, Rodgau, Germany).
Live cell imaging. Cells were cultured in eight-well Lab-Tek-chambered
cover glasses (Nunc, Langenselbold, Germany). During imaging, cells
were maintained at 371C in DMEM without phenol red and complemented with
20mM HEPES buffer and 10% fetal calf serum. We used a Leica SP2 laser
scanning confocal microscope (Leica Microsystems, Wetzlar, Germany) with a
 63 oil immersion lens.
CD95 DISC immunoprecipitation. A total of 1 10
7 HeLa-CD95 cells
were lysed in lysis buffer, without or with anti-APO-1 stimulation, divided into
two equal parts and the DISC immunoprecipitation was performed by using 5mg
anti-CD95 (anti-APO-1) antibody together with 30ml of Protein-A-Sepharose.
Immunoprecipitations were performed overnight at 41C, and then beads were
washed ﬁve times with 20 volumes of lysis buffer and subjected to western blot
analysis as described above.
Stable siRNA expression. We used stable expression of siRNA as
published previously.
34 The siRNA FLIP vector or control empty vector were
transfected into the HeLa-CD95 cell line as described earlier. The knockdown of
caspase-8 was carried out with a pSilencer 3.1-H1 Neo vector. The siRNA target
sequence was 50-GGGTCATGCTCTATCAGAT-30 as described.
35
Quantiﬁcation of western blot time series. The western blots were
developed using detection with a CCD camera or scanned and analyzed with
ImageJ (http://rsb.info.nih.gov/ij/). The local background from the bands was
subtracted and their intensity was quantiﬁed. For normalization, the signal was
divided by the anti-tubulin signal. For alignment of time series from repeated
experiments,the signals were multiplied with a scalar to minimize the sum of mean-
squared distances of measurements at the same time points. Finally, the average
signal was computed and scaled.
Modelingandsimulation. Modelﬁttingandsimulationwas carriedoutusing
the Matlab toolbox PottersWheel (Natick, MA, USA).
36 The model was modiﬁed
from our previous publication.
30 The differential equations, kinetic parameters and
the details of the ﬁtting procedure can be found in the Supplementary information.
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